Paper42748486
Gut Microbiota Alterations in People Living With HIV: Dysbiosis, Immune Dysfunction and Therapeutic Perspectives.
El Mheddeb S and 4 others. Rev Med Virol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Gut Microbiota Alterations in People Living With HIV: Dysbiosis, Immune Dysfunction and Therapeutic Perspectives. Papers, record 42748486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42748486
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Gut Microbiota Alterations in People Living With HIV: Dysbiosis, Immune Dysfunction and Therapeutic Perspectives.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dysbiosis | Major topic |
| HIV Infections | Major topic |
| Gastrointestinal Microbiome | Major topic |
| Humans | |
| Probiotics | |
| Prebiotics | |
| Fecal Microbiota Transplantation |
Source PubMed
References133
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38061029 | Dysbiosis of gut microbiota and metabolites during AIDS: implications for CD4 + T cell reduction and immune activation. | AIDS | 2024 | https://conductscience.org/library/papers/38061029 | PubMed |
| 2 | 25599331 | Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. | Circ Res | 2015 | https://conductscience.org/library/papers/25599331 | PubMed |
| 3 | 30921452 | The Impact of Human Immunodeficiency Virus Infection on Gut Microbiota α-Diversity: An Individual-level Meta-analysis. | Clin Infect Dis | 2020 | https://conductscience.org/library/papers/30921452 | PubMed |
| 4 | 39090139 | Exploring the interplay between antiretroviral therapy and the gut-oral microbiome axis in people living with HIV. | Sci Rep | 2024 | https://conductscience.org/library/papers/39090139 | PubMed |
| 5 | 39984934 | Association between plasma short-chain fatty acids and inflammation in human immunodeficiency virus-associated neurocognitive disorder: a pilot study. | Lipids Health Dis | 2025 | https://conductscience.org/library/papers/39984934 | PubMed |
| 6 | 38215933 | Bacteroides and related species: The keystone taxa of the human gut microbiota. | Anaerobe | 2024 | https://conductscience.org/library/papers/38215933 | PubMed |
| 7 | 31647148 | Intestinal M cells: Tireless samplers of enteric microbiota. | Traffic | 2020 | https://conductscience.org/library/papers/31647148 | PubMed |
| 8 | 31748797 | Altered Gut Microbiota and Host Metabolite Profiles in Women With Human Immunodeficiency Virus. | Clin Infect Dis | 2020 | https://conductscience.org/library/papers/31748797 | PubMed |
| 9 | 36721148 | The gut microbiome in Alzheimer's disease: what we know and what remains to be explored. | Mol Neurodegener | 2023 | https://conductscience.org/library/papers/36721148 | PubMed |
| 10 | 34280844 | Cerebrospinal fluid immune markers and HIV-associated neurocognitive impairments: A systematic review. | J Neuroimmunol | 2021 | https://conductscience.org/library/papers/34280844 | PubMed |
| 11 | 40393170 | The relationship between tryptophan metabolism and gut microbiota: Interaction mechanism and potential effects in infection treatment. | Microbiol Res | 2025 | https://conductscience.org/library/papers/40393170 | PubMed |
| 12 | 26269668 | Role of the normal gut microbiota. | World J Gastroenterol | 2015 | https://conductscience.org/library/papers/26269668 | PubMed |
| 13 | 40104586 | Understanding dysbiosis and resilience in the human gut microbiome: biomarkers, interventions, and challenges. | Front Microbiol | 2025 | https://conductscience.org/library/papers/40104586 | PubMed |
| 14 | 37153621 | Relevance of biomarkers indicating gut damage and microbial translocation in people living with HIV. | Front Immunol | 2023 | https://conductscience.org/library/papers/37153621 | PubMed |
| 15 | 39379604 | Type 17 immunity: novel insights into intestinal homeostasis and autoimmune pathogenesis driven by gut-primed T cells. | Cell Mol Immunol | 2024 | https://conductscience.org/library/papers/39379604 | PubMed |
| 16 | 37583444 | Gut dysbiosis associates with cytokine production capacity in viral-suppressed people living with HIV. | Front Cell Infect Microbiol | 2023 | https://conductscience.org/library/papers/37583444 | PubMed |
| 17 | 32978698 | The Combinatorial Effect of Acetate and Propionate on High-Fat Diet Induced Diabetic Inflammation or Metaflammation and T Cell Polarization. | Inflammation | 2021 | https://conductscience.org/library/papers/32978698 | PubMed |
| 18 | 32323556 | Review on the Alteration of Gut Microbiota: The Role of HIV Infection and Old Age. | AIDS Res Hum Retroviruses | 2020 | https://conductscience.org/library/papers/32323556 | PubMed |
| 19 | 37691753 | Fecal Microbiota Transplantation in Human Immunodeficiency Virus-Infected Patient Population: A Systematic Review and Meta-Analysis. | Gastroenterology Res | 2023 | https://conductscience.org/library/papers/37691753 | PubMed |
| 20 | 38310301 | Differential effects of antiretroviral treatment on immunity and gut microbiome composition in people living with HIV in rural versus urban Zimbabwe. | Microbiome | 2024 | https://conductscience.org/library/papers/38310301 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42748486
GET https://conductscience.org/api/papers/v1/42748486/references?page=2